ORIGINAL RESEARCH
Published on 10 Jun 2022
Untargeted LC-HRMS Based-Plasma Metabolomics Reveals 3-O-Methyldopa as a New Biomarker of Poor Prognosis in High-Risk Neuroblastoma
doi 10.3389/fonc.2022.845936
- 2,926 views
- 6 citations
3,956
Total downloads
13k
Total views and downloads
ORIGINAL RESEARCH
Published on 10 Jun 2022
ORIGINAL RESEARCH
Published on 27 Apr 2022
ORIGINAL RESEARCH
Published on 09 Dec 2021
ORIGINAL RESEARCH
Published on 21 Sep 2021
OPINION
Published on 01 Jul 2021